Caliper Technologies - CALP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caliper Technologies - CALP

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (98)	8/17/2006 3:23:15 PM
From: tuck	Read Replies (1) of 114

>>11:01AM Caliper Life Sciences unit Xenogen announced a target validation collaboration with Schering-Plough (CALP) 4.91 +0.31 : Xenogen Biosciences, acquired on August 9, 2006, by Caliper Life Sciences (CALP), today announces a target validation collaboration with Schering-Plough Corporation (SGP), under which Xenogen Biosciences will utilize its proprietary Serial Phenotyping Compression Technology to characterize high value targets resulting from drug discovery research conducted by the Schering-Plough Research Institute. Financial terms of the deal were not disclosed.<< Courtesy Briefing.com Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next